跳至主要内容
临床试验/NL-OMON22174
NL-OMON22174尚未招募不适用

Infusion of ex vivo-cultured allogeneic NK cels in acute myeloid leukemia patients not eligible for stem cell transplantation (a phase I dose escalation study).

Radboud University Nijmegen Medical Centre0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
15

研究概览

简要总结

Spanholtz J, Tordoir M, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte T, Dolstra H. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy. PLoS One. 2010;5(2):e9221.

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. AML patients > 65 year of age;
  • 2. Absence of a HLA-Cw ligand for an inhibitory KIR (i.e. homozygous Cw group 1 or 2);

排除标准

  • 1. Patients candidates for SCT;
  • 2. Progressive disease, no change or only minor response following induction and consolidation therapy;

研究者

发起方
Radboud University Nijmegen Medical Centre

相似试验